MedTrace Logo

4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis

NCT02807298 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2016-06-21

No results posted yet for this study

Summary

This study compared the anesthetic efficacy between Lignocaine and articaine administering it intraligamentarly using ligajet in twenty five female patients having irreversible pulpitis on bilateral mandibular molars. At 5minutes of post injection, the teeth were isolated with rubber dam and access performed. Patients were instructed to definitively rate any pain felt during endodontic procedure. If patient felt pain, the treatment was immediately stopped and the patient rated their discomfort using Heft Parker VAS. The extent of access achieved when the patient felt pain was recorded as within dentin, entering the pulp chamber or initial file placement. The success was defined as the ability to access and instrument the tooth without pain (VAS score of zero) or mild pain (VAS rating\<54mm).

Conditions

  • Irreversible Pulpitis

Interventions

DRUG

4%articaine

intraligamentary injections of 0.9 ml of 4%articaine and 1:100,000 epinephrine

DRUG

2% Lignocaine

Intraligamentary injections of 1.8 ml of lidocaine and 1:100,000 epinephrine

DRUG

Epinephrine

Intraligamentary injections of 1.8 ml of lidocaine and 1:100,000 epinephrine

Sponsors & Collaborators

  • Dr. D. Y. Patil Dental College & Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-10-31
Completion
2014-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02807298 on ClinicalTrials.gov